Kura Oncology (KURA) News Today $6.29 +0.01 (+0.10%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KURA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Kura Oncology (NASDAQ:KURA) Stock Crosses Below 200-Day Moving Average - Should You Sell?July 10, 2025 | marketbeat.comKura Oncology Grants Stock Options to New Employees Under 2023 Inducement Option Plan - NasdaqJuly 5, 2025 | nasdaq.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | globenewswire.comKura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US - Investing.comJuly 2, 2025 | investing.comKura Oncology's (KURA) Overweight Rating Reaffirmed at Cantor FitzgeraldJune 26, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of "Moderate Buy" by AnalystsJune 23, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Receives "Outperform" Rating from WedbushJune 20, 2025 | marketbeat.comKura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlookJune 15, 2025 | investing.comKura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association CongressJune 12, 2025 | globenewswire.comLightning Round: 'Wait and see situation' with Papa John's, says Jim CramerJune 12, 2025 | msn.comBrokers Issue Forecasts for Kura Oncology FY2026 EarningsJune 10, 2025 | marketbeat.comKura Oncology Grants Stock Options To New Hires Under Inducement PlanJune 7, 2025 | nasdaq.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.comJMP Securities Reiterates "Market Outperform" Rating for Kura Oncology (NASDAQ:KURA)June 4, 2025 | marketbeat.comTwo Sigma Investments LP Sells 42,120 Shares of Kura Oncology, Inc. (NASDAQ:KURA)June 4, 2025 | marketbeat.comNuveen Asset Management LLC Lowers Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)June 4, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Up - What's Next?June 3, 2025 | marketbeat.comASCO25: Kura’s Phase II ziftomenib results trigger NDA acceptance from FDAJune 3, 2025 | finance.yahoo.comKura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual MeetingJune 2, 2025 | globenewswire.comFDA Grants Priority Review for Kura Oncology, Inc. (KURA) and Kyowa Kirin’s ZiftomenibJune 2, 2025 | insidermonkey.comSquarepoint Ops LLC Takes $799,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)June 2, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AMLJune 1, 2025 | globenewswire.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Two Sigma Advisers LPMay 30, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMay 30, 2025 | marketbeat.comKura Oncology at TD Cowen Summit: Strategic Innovations in Menin InhibitorsMay 29, 2025 | uk.investing.comCantor Fitzgerald maintains Overweight on Kura Oncology stockMay 26, 2025 | uk.investing.comKura Oncology (NASDAQ:KURA) Trading Down 4.7% - What's Next?May 25, 2025 | marketbeat.comKura Oncology to present trial results for AML treatmentMay 24, 2025 | investing.comRafferty Asset Management LLC Grows Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)May 24, 2025 | marketbeat.comKura Oncology, Inc. (KURA) and Kyowa Kirin to Present Promising Ziftomenib Data at ASCO 2025May 23, 2025 | insidermonkey.comMillennium Management LLC Buys 1,521,954 Shares of Kura Oncology, Inc. (NASDAQ:KURA)May 23, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual MeetingMay 22, 2025 | globenewswire.comVelan Capital Investment Management LP Buys Shares of 150,000 Kura Oncology, Inc. (NASDAQ:KURA)May 21, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Stock Position Raised by BNP Paribas Financial MarketsMay 21, 2025 | marketbeat.comKura Oncology to Participate in Three Upcoming Investor ConferencesMay 20, 2025 | globenewswire.comLeerink Partnrs Lowers Earnings Estimates for Kura OncologyMay 20, 2025 | marketbeat.comSuvretta Capital Management LLC Lowers Holdings in Kura Oncology, Inc. (NASDAQ:KURA)May 19, 2025 | marketbeat.comGraham Capital Management L.P. Takes $444,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)May 19, 2025 | marketbeat.comProsight Management LP Purchases 619,891 Shares of Kura Oncology, Inc. (NASDAQ:KURA)May 17, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Has $10.03 Million Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)May 17, 2025 | marketbeat.com977,920 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Bought by Jacobs Levy Equity Management Inc.May 16, 2025 | marketbeat.comVoya Investment Management LLC Decreases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)May 16, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) CongressMay 14, 2025 | globenewswire.comKura Oncology, Inc. (NASDAQ:KURA) Holdings Reduced by Foresite Capital Management IV LLCMay 12, 2025 | marketbeat.comDimensional Fund Advisors LP Buys 372,196 Shares of Kura Oncology, Inc. (NASDAQ:KURA)May 12, 2025 | marketbeat.comKura Oncology’s SWOT analysis: ziftomenib’s potential drives stock outlookMay 7, 2025 | investing.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Algert Global LLCMay 7, 2025 | marketbeat.comBVF Inc. IL Sells 804,292 Shares of Kura Oncology, Inc. (NASDAQ:KURA)May 6, 2025 | marketbeat.comKura Oncology to Participate in Bank of America Securities Healthcare ConferenceMay 6, 2025 | globenewswire.comFY2026 EPS Estimates for Kura Oncology Increased by AnalystMay 6, 2025 | marketbeat.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼1.311.01▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼26▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BEAM News IDYA News IRON News BLTE News CNTA News HRMY News ADPT News SRPT News TARS News IMCR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.